Inventor
JASCUR JULIA
CH5 patents
Patents
5 patentsUS9777061B2Oct 3, 2017
Treatment of cancer using a CD33 chimeric antigen receptor
NOVARTIS AG85 citations96
US10568947B2Feb 25, 2020
Treatment of cancer using a CLL-1 chimeric antigen receptor
NOVARTIS AG6 citations71
US12338287B2Jun 24, 2025
Treatment of cancer using a CD33 chimeric antigen receptor
NOVARTIS AG0 citations61
US11459390B2Oct 4, 2022
Phosphoglycerate kinase 1 (PGK) promoters and methods of use for expressing chimeric antigen receptor
NOVARTIS AG0 citations61
US10851166B2Dec 1, 2020
Treatment of cancer using a CD33 chimeric antigen receptor
NOVARTIS AG1 citations61